Naïve CD4+ T cells coordinate the immune response by acquiring an effector phenotype in response to cytokines. However, the cytokine responses in memory T cells remain largely understudied. We used quantitative proteomics, bulk RNA-seq and single-cell RNA-seq of over 40,000 human naïve and memory CD4+ T cells to generate a detailed map of cytokineregulated gene expression programs. We demonstrated that cytokine response differs substantially between naïve and memory T cells and showed that memory cells are unable to differentiate into the Th2 phenotype. Moreover, memory T cells acquire a Th17-like phenotype in response to iTreg polarization. At the single-cell level, we demonstrated that T cells form a continuum which progresses from naïve to effector memory T cells. This continuum is accompanied by a gradual increase in the expression levels of chemokines and cytokines and thus represents an effectorness gradient. Finally, we found that T cell cytokine responses are determined by where the cells lie in the effectorness gradient and identified genes whose expression is controlled by cytokines in an effectorness-dependent manner. Our results shed light on the heterogeneity of T cells and their responses to cytokines, provide insight into immune disease inflammation and could inform drug development.
Introduction A healthy immune system is characterized by efficient communication between cells, which facilitates a quick response to a wide variety of pathogens. This communication is mediated by cytokines. Upon binding to their receptors, cytokines trigger a signaling cascade which culminates with the induction of gene expression programs 1, 2 . This promotes the differentiation of target cells into effector cell types. This process is particularly relevant for CD4+ T cells, which coordinate the downstream response of various immune cells (e.g. CD8+ T cells, macrophages and B cells) 3 . Triggering of the T cell receptor (TCR) and co-stimulatory molecules activates naïve CD4+ T cells, which are then directed by cytokines to polarize into various T helper (Th) phenotypes. These include Th1, Th2 and Th17, which secrete IFN-γ, IL-4 and IL-17, respectively [4] [5] [6] [7] . Moreover, in response to transforming growth factor beta (TGFβ), naïve CD4+ T cells acquire regulatory potential (induced regulatory T cells, iTreg) and suppress effector T cell responses 8 .
Previous in vitro studies investigated how cytokines modulate T cell function [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] , increasing our understanding of cytokine-induced polarization. Nonetheless, most studies have focused exclusively on naïve CD4+ T cells, altogether excluding memory cells. This is in part due to the premise that, once T cells undergo stimulation and respond to a cytokine, the phenotype acquired by CD4+ T cells remains mostly stable. Recent studies have challenged this idea, providing evidence that cytokines can reprogram the phenotypes of polarized T cells 2, 19, 20 . For example, IL-6 can convert Treg cells to a pathogenic Th17-like phenotype under arthritic conditions 21 . Furthermore, Th17 cells upregulate TBX21 and IFN-γ in response to Th1polarizing cytokines 22 , and infection-induced Th17 cells from the gut can secrete a variety of inflammatory cytokines, e.g. the Th1 cytokine IFNγ 23 . These observations highlight the remarkable plasticity of CD4+ T cells and suggest that memory cells retain the ability to respond to cytokines. However, understanding the effects of cytokines on memory T cells is challenging because circulating memory T cells are heterogeneous, comprised of multiple subpopulations such as central and effector memory cells [24] [25] [26] .
Cytokines also play a central role in autoimmunity and are often tractable, and successful therapeutic targets. Twenty-five years ago, injectable IFN-β was approved as the first disease modifying therapy (DMT) for multiple sclerosis 27 , yet the therapeutic mechanism is still unknown. Another DMT for multiple sclerosis is an immune modulator which shifts the cytokine profile of pro-inflammatory Th1 cells to anti-inflammatory Th2 cells 28 . These observations are not yet fully understood and illustrate how increasing our understanding of cytokine responses is crucial for improved drug development.
Finally, genetic studies have implicated CD4+ T cells, and particularly memory T cells, in the biology of many common complex immune diseases [29] [30] [31] , suggesting that it is especially relevant to understand cytokine responses in memory T cells. Therefore, limiting the study of cytokines to the naïve T cell compartment could bias our understanding of the processes underlying pathologic inflammation.
In this study, we characterized the response of naïve and memory CD4 T cells to five different cytokine conditions influencing inflammation and immune diseases. To account for the dynamic nature of cytokine responses, we profiled cells at two different time points following stimulation. We also examined cells in the resting state, resulting in a total of 12 distinct cell states. We used these profiles to generate a detailed map of gene and protein expression changes induced by cytokines. This map leverages information from quantitative proteomics, RNA-sequencing and single-cell RNA-sequencing (scRNA-seq) of over 40,000 single T cells, thus providing a comprehensive resource with exceptional resolution. We found that naïve T cells responded differently to cytokines than memory T cells. At the single-cell level, we recapitulated previously described CD4+ T cell subpopulations and found that T cells did not form discrete groups of cells but instead formed a continuum characterized by a gradual increase in the expression level of chemokines, granzymes and other effector molecules.
Importantly, this gradient was present in the resting state, persisted after stimulation and determined how cells respond to cytokines by modulating the magnitude of cytokine-induced gene expression changes.
Results

Study design
To investigate the effects of cytokines on the two main subsets of human CD4+ T cells, we purified CD4+ CD25-CD45RA+ CD45RO-naïve T (TN) cells and CD4+ CD25-CD45RA- Figure 1A and Methods). We then stimulated the cells with anti-CD3/anti-CD28 coated beads in the presence of different cytokine cocktails (Figure 1A, Figure 1B and Supplementary Table 1 ). We selected cytokine cocktails to polarize TN and TM cells towards four major T helper phenotypes (Th1, Th2, Th17 and iTreg). In addition, we included IFN-β due to its role as a therapy in multiple sclerosis 32, 33 .
CD45RO+ memory T (TM) cells (Supplementary
In order to distinguish T cell responses to TCR/CD28-activation from responses induced specifically by cytokines, we stimulated cells with anti-CD3/anti-CD28 beads in the absence of any cytokines (Th0). Finally, we also cultured cells without neither stimulation nor cytokines (resting cells). We profiled gene expression (RNA-seq) for early transcriptional responses (16 hours after stimulation, before cell proliferation) and late transcriptional responses (5 days after stimulation, after cell proliferation), when cells are thought to acquire an effector phenotype. To comprehensively characterise cellular states at the late time point, we also profiled the whole proteome using isobaric labelling with two-dimensional liquid chromatography-tandem mass spectrometry (LC-MS/MS), as well as the transcriptome at the single cell level (scRNA-seq) (Methods).
Figure 1. TCR/CD28-activation induces cell type specific gene expression programs in CD4 + T cells. A)
Overview of the experimental design. B) List of cytokine conditions. C) PCA plots from the whole transcriptome (upper panel) and proteome (lower panel) of TN and TM cells. Different colors correspond to cell types and different shades to stimulation time points. D) Gene expression changes at the RNA and protein levels by comparing TCR/CD28-activated (Th0) cells to resting cells. Upregulated genes are in red and down-regulated genes are in blue. Different shades indicate different fold-change thresholds. E) A selection of significantly enriched pathways (with enrichment scores > 0.7) from genes and proteins differentially expressed after five days of activation using the 1D enrichment method.
TCR/CD28-activation induces well-defined gene expression programs in naïve and memory T cells
To understand TN and TM cell responses to T cell activation (TCR/CD28-activation), we compared the transcriptomes of activated and resting cells. We observed that the main source of variation across the full transcriptome and proteome was T cell activation, with resting cells clustering separately from activated cells ( Figure 1C) . Activated cells also clustered by duration of stimulation (16 hours and five days) and cell type (TN and TM), suggesting that the response to T cell stimulation is dynamic and cell type specific ( Figure 1C) . We then tested for differential RNA and protein expression between resting and activated (Th0-stimulated) TN and TM cells. We identified a large number of changes which develop in response to stimulation (Figure 1D , Supplementary Tables 2 and Supplementary Table 3 ). At the RNA level, 8,333 and 7,181 genes (corresponding to approximately 40% of the transcriptome) were differentially expressed after 16 hours of activation in TN and TM cells, respectively. This number was comparable after five days (7, 705 and 7, 544 in TN and TM cells) . At the protein level, we identified 4,009 and 3,443 differentially expressed proteins (approximately 35% of the proteome data) after five days of activation in TN and TM cells, respectively. These genes formed a well-defined expression program characterized by upregulation of the cell cycle and targets of the E2F family of transcription factors, as well as the type I IFN response ( Figure   1E and Supplementary Table 4 ). Conversely, TN and TM cells downregulated components of the respiratory chain complex in response to activation ( Figure 1E ). This is in line with previous observations suggesting that T cell activation induces proliferation and profound metabolic changes to support effector responses 34 . Importantly, these conclusions were consistent between RNA and protein.
Cytokines induce cell type specific gene expression programs in naïve and memory CD4+ T cells
We next investigated how cytokines modulate gene expression in TN and TM cells. We first performed PCA on the full proteome and transcriptome, treating time points and cell types independently. While there were few cytokine effects at 16 hours (Supplementary Figure   1B) , we observed clear clustering by cytokine condition at five days (Figure 2A ) that were consistent between transcriptome and proteome. To disentangle cytokine effects from those of T cell activation (TCR/CD28-activation), we compared stimulated cells exposed to cytokines to Th0-stimulated cells ( Supplementary Table 2 and Supplementary Table 3 ). Most cytokine induced changes were only apparent after five days of stimulation ( Figure 2B) , with the exception of IFN-β. For example, Th17-stimulation induced only 42 differentially expressed genes after 16h in naïve cells at the RNA level, compared to 1,818 differential genes induced after 5 days. This pattern was similar for other cytokine conditions. In contrast, IFN-β induced a large number of early transcriptional changes (357 genes at 16h and 329 after 5 days in TN cells), reflecting its' role in the fast response to viruses. These results suggest that early changes in gene expression are dominated by the effects of T cell activation alone, while the expression programs characteristic of differentiated Th cells are apparent at the later stages of stimulation. This implies that cytokine polarization occurs not in parallel but after the initiation of T cell activation.
Figure 2. Cytokines induce cell type specific gene expression programs in CD4 + T cells. A)
PCA plot from the full transcriptome and proteome of TN and TM cells following five days of cytokine stimulations. Only stimulated cells were included in this analysis. B) Gene expression changes at the RNA and protein levels from pairwise comparisons between cytokine-stimulated cells and Th0stimulated cells. Up-regulated genes are in red and down-regulated genes are in blue. Different shades indicate different fold-change thresholds. C) A selection of significantly enriched pathways (with enrichment scores > 0.7) from differentially expressed genes and proteins using the 1D enrichment method. D) Volcano plots highlighting significant differences in gene and protein expression between Th17 and iTreg-stimulated TN and TM cells. Red indicates expression upregulation in iTreg with respect to Th17-stimulation, blue indicates expression upregulation in Th17 with respect to iTreg-stimulation. Labels were added to IL17, FOXP3 and the top 20 most differentially expressed genes. E) Cell state specific gene signatures defined using jointly RNA and protein expression. Colours encode normalized (Z-scored) gene and protein expression levels. Example genes for each signature are labeled.
Since cytokine induced effects mainly manifested five days after stimulation, we subsequently focused on the late time point to further elucidate changes in gene and protein expression driven by different cytokines. We then compared these effects between TN and TM cells. In general, the number of cytokine-induced changes in RNA and protein expression was comparable between TN and TM cells ( Figure 2B) . However, Th2-stimulation clearly triggered different responses between the two cell types, resulting in differential expression of 944 genes in TN cells compared to 49 in TM cells. We observed the same trend at the protein level, where 290 proteins were differentially expressed in TN cells but no differences were detected in TM cells in response to Th2-stimulation ( Figure 2B ). This was true despite TM cells expressing comparable levels of the IL-4 receptor than TN cells ( Supplementary Figure 2A ).
This suggested that TM cells cannot be polarized towards the Th2 phenotype.
We next sought to translate these observations to cellular functions and pathways. We observed that the genes and proteins differentially expressed upon cytokine stimulation formed well-defined expression programs and were enriched in relevant pathways (Figure 2C and Supplementary Table 4 ). As expected, stimulation with IFN-β induced upregulation of the type I IFN response in both TN and TM cells, while Th2-polarization of TN cells suppressed this pathway, likely reflecting that Th2-polarization involves IFN-γ blockade. Importantly, these effects were concordant between RNA and protein. Furthermore, we found that Th1stimulation of TN cells induced metabolic changes such as increased cholesterol and terpenoid synthesis, while Th2-stimulation increased the expression of genes involved in amino acid metabolism ( Figure 2C) . Interestingly, some pathways showed opposite effects between TN and TM cells upon cytokine stimulation. For example, while Th17-stimulation of TN cells induced downregulation of the type I IFN response, Th17-stimulation of TM cells increased the activity of this same pathway. We observed a similar pattern upon iTreg-stimulation, with the type I IFN response being upregulated in TM but not in TN cells (Figure 2C) . These observations suggest that Th17 and iTreg-stimulation conditions induce different cell states in TN than in TM cells.
Th17 and iTreg cells have been extensively linked to autoimmune inflammation and immune suppression. Polarization to both of these cell states requires the presence of TGF-β and there is evidence of interconversion between the two cell phenotypes 21 , suggesting that their functions may be interrelated. Consistent with these observations, we found that Th17 and iTreg-stimulated TN and TM cells were more similar to each other than to any other cell state and formed a single cluster on the PCA plot (Figure 2A) . This similarity was captured by both proteome and transcriptome. This was in sharp contrast with TN cells, where the two cytokineinduced cell states formed separate groups. Importantly, both cell types expressed comparable levels of the TGF-β and IL2 receptors ( Supplementary Figure 2B and Supplementary Figure 2C ). To further test whether Th17 and iTreg-stimulation induced the same phenotype in TM cells, we compared the expression of genes between the two cell states (Figure 2D , Supplementary Table 2 and Supplementary Table 3 ). Only 42 genes and no proteins were differentially expressed between the two cytokine conditions in TM cells at the selected thresholds (LFC > 1 at 0.05 FDR for RNA-seq and LFC > 0.5 at 0.1 FDR for proteomics). In contrast, in TN cells 733 genes and 455 proteins were differentially expressed between iTreg and Th17-stimulated cells ( Figure 2D ). In particular, iTreg-stimulated TN cells expressed higher levels of FOXP3, IKZF4 and LGALS3, while Th17-stimulated TN cells expressed higher levels of IL17F, TNFRSF8 and PALLD. Therefore, while TN cells acquire different phenotypes upon Th17 and iTreg-polarization, both cytokine conditions polarize TM cells towards the same cell state.
Cell state specific gene signatures from proteome and transcriptome
Our results suggested that these cytokines act in a cell type specific manner to induce five well-defined cell states in TN cells (Th1, Th2, Th17, iTreg and IFN-β) and three well-defined cell states in TM cells (Th1, Th17/iTreg and IFN-β, while lack Th2 response). We next set out to identify the most specific genes characterizing these cell states. We confirmed that RNA and protein expression showed high correlation in our data, both at the sample and at the gene level (Supplementary Figure 1C and 1D) . Thus, we applied a multi-omics approach which leveraged both layers of molecular information to derive robust cell state gene signatures (Methods). This approach allowed us to identify genes with concordant effects in the two assays, thus increasing our confidence that we captured true cytokine-induced effects.
In brief, we identified differentially expressed RNA-protein pairs and asked if any of these pairs were present at a higher level in one cell state compared to the rest. In this way, we derived a measurement of cell state specificity for each gene, where genes with higher specificity than expected by chance were included in a cell state specific proteogenomic signature (Methods).
Because we derived these signatures jointly from transcriptome and proteome, our signatures were sensitive to relative changes in both RNA and protein levels.
In TN cells we identified 105 signature genes corresponding to one of the five different cell states (5 genes for Th1, 20 for Th2, 20 for Th17, 10 for iTreg, and 50 for IFN-β) (Figure 2E and Supplementary Table 5 ). The TN IFN-β signature contained well established antiviral genes involved in IFN-regulated functions such as RNAse L induction (OAS2, OAS3), GTPase activity (MX1, MX2) and cell lysis (GZMA, GZMB) 35 . Signatures of other TN cell states also included well known hallmark genes, such as GATA3 (Th2 signature), TBX21 (Th1 signature) and FOXP3 (iTreg signature) (Figure 2E ). This illustrated that our approach accurately identified known markers of cytokine polarization. Moreover, we observed genes highly specific to Th1 (ANXA3), Th2 (MAOA, LIMA1, MRPS26), Th17 (TNFRSF8, RUNX1, PALLD) and iTreg (LMCD1, LGALS3, CCL5) cell states which have not been previously described in the context of cytokine polarization.
We performed the same analysis for TM cells, where we identified 162 signature genes corresponding to one of the three cell states (three for Th1, 145 for Th17/iTreg and 14 for IFNβ genes) (Figure 2E and Supplementary Table 5 ). Since Th17 and iTreg-stimulated TM cells overlapped on both the RNA and protein levels, we treated them as one phenotype in this analysis. We observed that the IFN-β signature was substantially different in TM compared to TN cells (only 6 genes overlapped between both signatures). Nonetheless, it contained well known antiviral genes such as HERC6 and GZMB. Several Th17/iTreg TM signature genes were also present in the iTreg and Th17 signatures derived from TN cells (CCL5, LGALS3, TNFRSF8) or had been previously linked to one of the two phenotypes in the literature (BACH2, BATF3, AHR), suggesting that Th17/iTreg TM cells might have overlapping functions with the Th17 and iTreg states in TN cells. The signature genes identified with our approach provide a valuable resource for future follow-up studies in specific biological contexts or disease settings.
Single-cell transcriptomics reveals a CD4+ T cell effectorness gradient
Our results showed that the gene expression programs induced in response to cytokines can differ substantially between TN and TM cells. While TN constitute a rather uniform cell population, TM cells are composed of multiple subpopulations including central (TCM) and effector (TEM) memory cells, as well as effector memory cells re-expressing CD45RA (TEMRA).
Given this heterogeneity, we speculated that the observed differences in cytokine responses could be explained in two ways: i) TM cells, as a whole, are unresponsive to certain cytokines, or ii) specific subpopulations of TM cells respond to cytokines but the measured bulk gene expression profiles are dominated by a large proportion of unresponsive cells. To address this, we profiled single-cell gene expression in a total of 43,112 TN and TM cells, which included resting cells, as well as cells exposed to Th0, Th2, Th17 and iTreg-stimulation.
First, we isolated TN and TM cells from four healthy individuals and quantified gene expression
in the resting state using droplet-based single-cell RNA-sequencing 36 
(Methods and
Supplementary Figure 3A) . In total, we profiled 5,269 resting T cells (2,159 TN and 3,110 TM cells respectively), with an average of 1,146 genes detected per cell. We identified 64 highly variable genes, which we used for dimensionality reduction and embedding with the uniform manifold approximation (UMAP) 37 , as well as for unsupervised cell clustering (Methods). We identified five distinct groups of cells ( Figure 3A) which we annotated as TN, TCM, TEM, TEMRA and natural T regulatory (nTreg) cells based on the expression of well established cell type markers (Figure 3B and Supplementary Table 6 ). TEMRA cells showed a distinct transcriptional profile characterized by high expression of cytotoxic genes (eg. PRF1, CCL4, GZMA, GZMH), consistent with previous observations 25 . Importantly, these cells expressed comparable levels of CD4 and no CD8. The proportions of cells detected in each cell subpopulation were comparable across all biological replicates ( Figure 3A) . We observed that TN cells were mostly a homogeneous group of cells. However, a small percentage of TEMRA cells were originally isolated as TN cells (as they re-express the CD45RA marker) and could only be correctly identified at the single-cell level. In addition, our results suggested that CD4+ T cells do not consist of discrete subpopulations.
Instead, different subsets of T cells localized to different areas of the same population within the UMAP space ( Figure 3A) , suggesting that they form one population with multiple interrelated transcriptional states. To investigate the relationships between these states we applied pseudotime analysis 38 to determine if the cells formed a continuous trajectory. We identified a clear trajectory, starting with TN cells and gradually progressing towards TM cells.
The cells at the beginning of this trajectory expressed high levels of naïve markers (e.g.
CD62L, CCR7 and LRRN3). In contrast, the end of the trajectory was enriched in cells expressing high levels of cytotoxic molecules (e.g. GZMA, GZMB and PRF1). This approach confirmed that transcriptionally CD4+ cells formed a natural progression from the least effector (TN) to the most effector (TEMRA) cell subset (Figure 3C) , with nTreg cells branching separately from the main trajectory. Furthermore, the expression of cytokines and chemokines, such as IL32, CCL4 and CCL5, gradually increased along the pseudotime axis (Figure 3D and Supplementary Table 7 ). Therefore, this pseudotime ordering corresponded to the levels of T cell effector functions, which formed a gradient. We refer to this as effectorness. Taken together, our results demonstrate that CD4+ T cells are a continuum of cells with varying effectorness, rather than a collection of discrete cell subsets.
Single-cell transcriptomics separates cells by effectorness and cytokine-induced cell state
Given the observed effectorness gradient we next assessed if this influenced cell responses to T cell activation and cytokine polarization. Therefore, we exposed TN and TM cells to Th0, Th2, Th17 and iTreg-stimulation and profiled single-cell gene expression five days following stimulation. We combined the data obtained from these four conditions into a single data set, which contained single cell transcriptomic profiles of 37,843 cells, of which 18,786 were TN and 19,057 were TM cells, respectively. We used these single-cell profiles to identify 220 highly variable genes, which were used for dimensionality reduction and UMAP embedding. We observed that TN and TM cells formed one single cluster of cells but separated into two different areas of the UMAP space (corresponding to UMAP1, Figure 4A ), which is in agreement with our observations from resting T cells. We also found that cells exposed to different cytokines localized to different areas of the UMAP space ( Figure 4B ). This was confirmed by a high expression of literature markers associated with the respective cytokines ( Figure 4C) . For example, iTreg-stimulated TN cells localized to an area with high expression of CTLA4, while the area associated with Th17-stimulated TN cells showed high RORA expression. The area enriched in Th17-stimulated TM cells showed higher levels of IL17F (Figure 4C) . Moreover, cells in these areas also showed higher expression of the corresponding genes identified from our proteogenomic signature analysis (Supplementary Figure 3B) , confirming a high overlap between our bulk and single-cell observations. Importantly, while the response of TN cells to cytokines was homogeneous, TM cells exposed to cytokines fragmented into multiple groups (Figure 4B ), suggesting the existence of different gene expression programs specific to TM subpopulations.
Figure 4. CD4+ T cells separate by effectorness and cytokine-induced cell state. A)
UMAP embedding of single stimulated T cells into a two-dimensional space. Green corresponds to TN and purple to TM cells. B) Density plots highlighting cells based on the cytokines they were exposed to. C) Expression of cytokine markers described in the literature. Each dot represents a single cell and colors correspond to the expression level of a gene in each cell. D) UniFrac distances between TN and TM cells exposed to different cytokines summarized in a correlation plot. E) Th0-stimulated TN and TM cells ordered in a branched pseudotime trajectory. Each cell is colored by cell type (left panel) or pseudotime value (right panel). F) Heatmap of the most variable genes along the Th0 pseudotime trajectory (from Monocle). The X axis represents cells ordered by pseudotime (from left to right) and colors correspond to the scaled (Z-scored) expression of each gene in each cell. G) An overlay of the cells' effectorness values into the UMAP embedding described in panel A. Cells exposed to each cytokine condition were ordered in separate branched pseudotime trajectories using Monocle, these trajectories were subsequently combined into a single numeric variable called effectorness.
Based on the observations from bulk gene expression, we asked whether the absence of response to Th2-stimulation in TM cells was characteristic of the entire population of cells or if a specific subpopulation responded to Th2-stimulation but was masked by a majority of unresponsive cells. Interestingly, Th0 and Th2-stimulated TM cells predominantly localized to the same UMAP areas (Figure 4B) . We used UniFrac distances 39 , to formally test if Th0 and Th2-stimulated TM cells overlapped (i.e. localized to the same clusters) or formed different groups. The UniFrac method first groups cells in a dendrogram based on their transcriptome.
Next, it compares the average position of cells from different samples in the dendrogram and summarizes these differences in a single distance metric 40 . A UniFrac distance of 0 indicates that cells from the two groups have exactly the same composition, while a distance of 1 indicates that the groups form entirely separate clusters. We confirmed that Th0 and Th2stimulated TM cells nearly perfectly overlapped (UniFrac distance = 0.047) ( Figure 4D) indicating that no individual subpopulations of TM cells were capable of responding to Th2stimulation. Instead, the observed lack of response was a uniform characteristic of all TM cells.
Our observations from the bulk data also support that TM cells polarize to the same cell state in response to both Th17 and iTreg-stimulation. We confirmed this at the single cell level, where cells from these two conditions localized to the same UMAP areas. The UniFrac distance between these cell states was 0.015 in TM cells, compared to 0.164 in TN cells ( Figure   4D ). Thus, we concluded that in response to Th17 and iTreg-stimulation TM cells converge on the same cell state. This is not driven by any subpopulation of TM cells and is rather a general characteristic of memory T cell biology. Interestingly this population expressed high levels of IL17F, suggesting that iTreg-stimulation in TM cells induces a Th17-like phenotype.
We next assessed how the effectorness gradient affected cell response to stimulation in the presence of cytokines. We observed that the most widely used markers of central and effector memory T cells (i.e. CD62L and CCR7) significantly changed in expression patterns following activation (Supplementary Figure 3C) , making the annotation of individual TM subpopulations challenging. To overcome this, we applied pseudotime ordering to infer the effectorness of each single cell. In brief, we ordered cells within each cytokine condition into branched pseudotime trajectories. This resulted in four cytokine-specific pseudotime trajectories (Th0, Th2, Th17 and iTreg). First, we analyzed Th0-stimulated cells and confirmed that the trajectory inferred for this cell state showed a similar pattern to that observed in resting cells (Figure 4E and Supplementary Table 7 ). We observed a gradual increase in the expression of cytokines and effector molecules which progressed from TN to TM cells. A similar pattern was apparent in other cytokine stimulations, with TN cells localizing to the beginning and TM cells to the end of the respective trajectories ( Supplementary Figure 4 and Supplementary Table 7 ).
Furthermore, the end of these trajectories contained cells expressing high levels of genes specific to TEMRA cells (eg. GZMA, GZMB, PRF1). Thus, we concluded that pseudotime can correctly order cells by effectorness. Finally, we combined the pseudotime values inferred from the four trajectories into a single numeric variable corresponding to T cell effectorness (Methods). Interestingly, a large proportion of this variable was captured by the first UMAP component (Figure 4G) . In conclusion, scRNA-seq enabled successful assignment of a cytokine-induced cell state and an effectorness value to each cell. Despite being separate biological variables, we hypothesized that these two axes of variation could interact to determine the transcriptional profile of each individual T cell.
Effectorness determines the response of CD4+ T cells to cytokines
Next, we used the combined single-cell transcriptomes from all cytokine conditions (i.e. merged data set) to perform unsupervised clustering. We identified 17 clusters of T cells (Figure 5A and Supplementary Table 6 ) and used the trajectory analyses results to uniquely annotate each of the clusters as T cells of a given effectorness exposed to a given cytokine condition. For instance, we identified clusters of Th0, Th2, Th17 and iTreg-stimulated TN cells, as well as a cluster formed of roughly equal numbers of Th17 and iTreg-stimulated TN cells, characterised by high expression of TNF-signaling molecules (eg. IL2, DUSP2, REL, TNF) ( Figure 5A and Figure 5B ). Moreover, we identified four clusters of Th0-stimulated TM cells, which we annotated as stimulated TM cells of low, medium and high effectorness, as well as stimulated TEMRA. The same was true for Th17/iTreg-stimulated TM cells, which localized into four groups with different effectorness (TM low, TM med, TM high and TEMRA cells). We also identified a group of nTreg cells, which expressed canonical markers such as FOXP3, CTLA4 and TNFRSF8. This cluster contained a comparable number of cells from all the profiled cytokine conditions, suggesting that cytokines do not modify the nTreg transcriptional program. Finally, we observed a small cluster formed of TN and TM cells expressing high levels of IFN-induced genes, as well as a cluster characterized by high expression of heat shock proteins (HSPs) and other markers of cellular stress (Figure 5A and Figure 5B ). We identified 210 genes significantly associated with effectorness ( Supplementary Table 8 ).
Of these, the vast majority (203 genes) were further regulated by cytokines. In particular, 12 genes showed independent effects of cytokine-stimulation and effectorness, while 191 showed an interaction effect. Within the genes with interaction effects, 12 showed an effectorness dependency only in the presence of a given cytokine, while 179 showed effectorness dependency ubiquitously (across all cytokine conditions), with the strength of this effect regulated by cytokines. We next filtered genes by their effect sizes and identified 25 genes with a strong effectorness dependency, irrespective of cytokine stimulation. These included the costimulatory molecule TNFRSF4 (encoding for OX40), which is known to be critical in the maintenance of memory T cell responses 41 , as well as effector molecules involved in target cell killing such as granulysin (GNLY), GMZA, CCL3 and IFNG (Figure 5D ). The expression of these genes increased proportionally to T cell effectorness. In addition, we identified 37 and 16 genes strongly associated with effectorness upon Th17 and iTreg-stimulation, respectively. These genes included cytokines like IL2 (which decreases proportionally to effectorness upon Th17 and iTreg-stimulation) and IL9 (which increases proportionally to effectorness for the same conditions) ( Figure 5D) . Moreover, genes induced by type I IFNs (eg. ISG15, IFIT1, IFIT2, IFIT3) also increased proportionally to effectorness upon iTreg and Th17-stimulation. This is in line with our observation from bulk RNA and protein expression, where we found that the type I IFN response was differentially regulated in TN and TM cells in response to Th17 and iTreg-stimulation (Figure 2C) . To further validate these effects at the protein level, we isolated Figure 5) . We then stimulated cells in the presence or absence of Th17 polarizing cytokines and quantified IFNγ and IL-9 expression upon restimulation (Methods). Our results replicated the observations from single-cell RNA-seq.
TN, TCM and TEM cells (Supplementary
Namely, the levels of IFNγ increased proportionally to effectorness in both Th0 and Th17stimulated cells (Figure 5E) . In contrast, the levels of IL9 only marginally correlated with effectorness in Th0 cells, but substantially increased with effectorness in Th17-stimulated cells (Figure 5E ). This confirmed our observations from the transcriptome and suggested that key T cell functions such as cytokine secretion are under the control of both effectorness and environmental cues.
In summary, we identified a gradient of T cell effectorness which is present both before (resting state) and after stimulation. We further showed that this effectorness determines the response of single T cells to cytokines in their environment.
Discussion
Cytokines have been extensively studied in the context of naïve T cell polarization, but the Our multi-omic data show that the response to cytokines can be strikingly different between naïve and memory T cells. While TN cells respond to all cytokine polarizing conditions by acquiring a distinctive phenotype, we observed that TM cells do not respond to Th2 polarization. Furthermore, we found that iTreg cells share a large proportion of their transcriptional program with Th17 cells, which is consistent with both cell states being generated in response to TGF-β 6, 8 . This is in line with previous evidence that iTreg cells can convert to Th17 in inflammatory contexts 21 . However, unlike naïve T cells, which upon iTreg-stimulation induced hallmark Treg markers such as FOXP3 and CTLA4, memory T cells converge on the same cell state in response to Th17 and iTreg-stimulation. This cell state is characterized by high levels of IL17F, suggesting that iTreg-stimulation in memory T cells induces a Th17-like phenotype. As such, our study demonstrates that memory T cells do not acquire a regulatory phenotype upon iTreg polarization. This is particularly relevant in the context of disease, given that the number of memory T cells increases with age 42 , potentially leading to a pro-inflammatory response to TGF-β.
In contrast, the response to IFN-β was conserved between naïve and memory T cells and, unlike Th polarization, was apparent even within 16h of stimulation. This is in line with the role of type I interferons in antiviral responses, which need to be triggered fast in order to prevent viral replication. Both naïve and memory T cells upregulated genes involved in RNAse L induction (OAS2, OAS3) that serve to degrade viral transcripts 43 , GTPase activity (MX1, MX2)
to inactivate viral capsids and ribonucleoprotein assembly 44 , as well as proteins involved in cell lysis (GZMA, GZMB) 35 .
Using single cell transcriptomics, we show that CD4+ T cells form a natural progression from naïve to highly effector memory cells, which is accompanied by upregulation of chemokines and cytokines. We called this gradient, present both at the resting state and after stimulation, T cell effectorness. This suggests that, transcriptionally, memory T cell subpopulations (e.g. TCM, TEM and TEMRA) are better described as stages in a continuous trajectory rather than as separate cell populations, as they have been traditionally described based on protein expression and surface markers 24 . Our results are in line with a similar trajectory, which was reported using simultaneous targeted quantification of mRNA and protein expression in single T cells 45 . Interestingly, a similar gradient is also present in innate T cells, as shown by a previous study where higher expression levels of effector molecules were negatively associated with ribosome synthesis and proliferative capacity 46 .
Importantly, the effectorness gradient described here closely recapitulates observations from immune cells isolated directly from tissues. Specifically, a previous study described the generation of memory T cells in the fetal intestine and profiled their transcriptome with singlecell resolution 47 . Cells from this study formed an equivalent trajectory, characterized by a smooth progression from the naïve to the memory state, and were accompanied by downregulation of naïve markers like CCR7 and upregulation of cytokines like IL32. Thus, our results could begin to explain how memory cells in tissues adapt in response to inflammation.
Finally, we demonstrate that effectorness determines how CD4+ T cells respond to cytokines.
In particular, we systematically identified genes which are regulated by cytokines in an effectorness-dependent manner, such as IFNG and IL9. Importantly, a number of these effects are also present at the protein level. Memory cells had previously been shown to upregulate IL-9 in response to TGF-β 48 , and it is known that this cytokine can also reprogram Th2 cells to an IL-9 secreting phenotype 20 . However, here we refined this observation to memory cells with high effectorness only (i.e. TEM or TEMRA cells). This is important given the role of TGF-β in Th17 cell biology, and especially since these cells show substantial diversity in vivo 23 . Our study suggests that cells with high effectorness that infiltrate tissues might start the strong responses to local cytokine environment. Future studies that use single-cell RNA-seq to profile inflamed tissues from immune disease patients will provide an opportunity to investigate these effects in greater detail directly in a disease context.
Our results demonstrate that memory cells can continue to adapt their phenotypes in response to Th17 cytokines, thus suggesting a mechanism which could generate the observed diversity.
Understanding this will be key in the development of drug targets for autoimmune disease, as IL-17 and other Th17-cytokines are known to promote inflammation, for example in MS patients and animal models of disease [49] [50] [51] .
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Methods
Cell isolation and in vitro stimulation
Blood samples were obtained from six individuals for the bulk assays (naïve and memory T cells were isolated from three independent individuals, respectively) and from four additional Cytokines were added at the same time as the stimulus (see Supplementary Table 1 for a full list of the cytokines used with product details and exact concentrations). Cells were harvested after 16 hours and 5 days of stimulation.
Bulk RNA-sequencing
A total of 3 x 10 5 cells were resuspended in 500 μl of TRIzol™ and stored the material at -80°C until further processing. After samples were thawed at 37°C, 100 μl chloroform were added and samples were centrifuged for 15 min at 4°C and 10,000g. The aqueous phase was collected and mixed at a 1:1 ratio with 70% ethanol (Qiagen). RNA was isolated from this mixture using the RNeasy MinElute Kit (Qiagen), and RNA quality was assessed using a Bioanalyzer RNA 6000 Nano Chip (Agilent Technologies). All samples had an RNA integrity number (RIN) above 8.5. Finally, sequencing libraries were prepared using the Illumina TruSeq protocol and sequenced on an Illumina HiSeq 2500 platform using V4 chemistry and standard 75 bp paired-end reads.
Proteomics
Pellets formed of up to 3 x 10 6 cells were isolated and washed twice with PBS, dried and stored at -20 C until protein extraction. Cell pellets were then lysed in 150 μl 0.1 M triethylammonium bicarbonate (TEAB) buffer (Sigma Aldrich) supplemented with 0.1% SDS and Halt protease and phosphatase inhibitor cocktail (100X, Thermo #78442). Pulse probe sonication (40% power, 4 C and 20 seconds) was performed twice using EpiShear™, after which the samples were incubated for 10 minutes at 96 C. Protein from cell lysates was quantified using the quick start Bradford protein assay (Bio-Rad) as specified by the manufacturer's instructions. Protein samples were finally divided into aliquots of up to 100 μg.
Protein aliquots were reduced with 5 mM tris-2-carboxymethyl phosphine (TCEP) buffer (Sigma Aldrich) and incubated for 1 hour at 60˚C to reduce disulfide bonds. Iodoacetamide and integration method based on the most confident centroid peak at the MS3 level. Only unique peptides for the protein groups were used for quantification. Peptides with average reporter signal-to-noise less than 3 were excluded from protein quantification.
Single-cell RNA-sequencing
Cells were resuspended in RPMI media to obtain a single-cell suspension with high cell viability. Next, cells were stained with a live/death dye (DAPI) and dead cells were removed 
Flow cytometry
Cells were washed with FACS buffer (PBS buffer supplemented with 1% FCS and 1 mM EDTA) by centrifugation and stained with the respective antibodies. Reactions were incubated for 30 minutes at 4°C. Following two washes with FACS buffer, samples were resuspended in 200 μl of FACS buffer and data was acquired using a Fortessa analyser (BD Bioscience). All data were processed with FlowJo (v9.9, TreeStar). 
RNA-seq data analysis
Sequencing reads were aligned to the reference human genome using STAR 53 (v2.5.3) and annotated using the hg38 build of the genome (GRCh38) and Ensembl (v87). Next, the number of reads mapping to each gene was quantified using featureCounts 54 (v1.22.2) . After quantification, reads mapping to the Y chromosome and the major histocompatibility complex (HLA) region (chr6:25,000,000-47,825,000) were removed from the analysis. The final result from this process was a counts table of RNA expression in each sequenced sample.
RNA counts were imported into R (v3.5.1) where normalization for library size and regularizedlogarithmic transformation of counts was performed using DESeq2 55 (v1.19.52) . We identified and removed batch effects using limma 56 (v3.35.15) . Exploratory data analysis was performed using ggplot2 (v3.0.0) and the base R functions for principal component analysis. Differential expression analysis was performed with DESeq2. More specifically, pairwise combinations were performed between any two conditions of interest, usually setting either resting or Th0stimulated cells as controls. Differentially expressed genes were defined as any genes with absolute log-fold changes (LFC) larger than 1 at a false discovery rate (FDR) of 0.05.
Proteomics data analysis
After quantification, protein abundances were normalised in order to allow comparisons between samples and plexes (mass spectrometry batches). Namely, protein abundance values were normalized to the total abundance of the respective sample (sample-wise normalization) and then scaled to the maximum abundance of the respective protein (protein-wise scaling). Data were then imported into R, where principal component analysis was performed using all the proteins with no missing values (proteins detected in all batches and samples) with base R functions. Finally, differential protein expression was analyzed by performing pairwise comparisons between any two conditions of interest. This was done using the moderated T test implemented in limma's eBayes function 56 . When testing for differential protein expression, only proteins detected in at least two biological replicates per condition were kept. Multiple testing correction was performed using the Benjamini-Hochberg procedure 57 . Finally, differentially expressed proteins were defined as any proteins with an absolute log-fold change larger than 0.5 at an FDR of 0.1.
Pathway enrichment analysis
Pathway enrichment analysis was performed using proteomics and RNA-seq data. To do so, genes detected at both the RNA and protein level were identified by matching gene names.
Next, genes were ranked by differential gene or protein expression, respectively, compared to either resting or Th0-stimulated TN and TM cells. Finally, pathway enrichment analysis was performed independently in the RNA and protein data using the Perseus software 58 (v1.6) and the 1D-annotation enrichment method 59 . The enrichment scores indicated whether the RNAs and proteins in a given pathway tended to be systematically up-regulated or down-regulated based on a Wilcoxon-Mann-Whitney test. A term was defined as differentially enriched if it had a Benjamini-Hochberg FDR < 0.05. Results were visualized in R using the pheatmap package (v1.0.10). For visualization, only unique pathways with an absolute enrichment score higher than 0.7, an FDR < 0.05 were kept. This was restricted to terms with biological relevance and that were included in either Reactome, KEGG or CORUM [60] [61] [62] .
Identification of cell state signatures from RNA and protein expression
The correlation between RNA and protein expression was evaluated by estimating log-fold changes (LFCs) with respect to the control (Th0) in each cytokine condition and computing the Pearson correlation between RNA and protein LFCs. This was done both sample-wise and gene-wise. Resting T cells were excluded from this analysis.
Proteomics and RNA-seq data were used jointly to identify gene signature associated with each cytokine induced cell state. First, both data sets were matched by gene name to identify a common set of genes detected at both the RNA and protein level. Next, the f-divergence cut-off index (fCI) method 63 was used to identify genes (RNA-protein pairs) with significant evidence of differential expression given their RNA counts and protein abundances. For any genes detected as significant by fCI, their normalized regularized-log (rlog) RNA counts 55 and scaled protein abundances were used to calculate specificity scores in RNA and protein datasets, respectively. To do so, replicates from each condition were first averaged. Next, the specificity of each gene in each cytokine induced cell state was defined by normalizing the expression of each gene or protein to the Euclidean mean across its different cell states, as described elsewhere 29 .
RNA specificity was defined as: Where Si,j is the specificity score of gene i in condition j. In order to give the same weight to proteomic and transcriptomic evidence, the RNA and protein weights (WRNA and Wprot) were set to 0.5.
To test which genes were more specific to one cell state than expected by chance, sample labels were randomly permuted and the specificity score was recalculated. Empirical P values were computed as the proportion of times the observed specificity score of a gene in a given cell state was larger than the corresponding permuted value. P values were corrected for the number of genes tested using the Benjamini-Hochberg procedure 57 . A total of 10,000 permutations were performed. Finally, proteogenomic signatures for each cytokine condition were defined as any genes with a specificity score larger than 0.7 and an FDR-adjusted P value lower than 0.1. This analysis was performed separately for naïve and memory T cells.
The functions used to derive proteogenomic signatures are publicly available as an R package on GitHub (https://github.com/eddiecg/proteogenomic).
Single-cell RNA-seq data analysis
Single-cell RNA-sequencing data were processed using the Cell Ranger Single-Cell Software Suite 36 (v2.2.0, 10X-Genomics). Namely, reads were first assigned to cells and then aligned to the human genome using STAR 53 , using the hg38 build of the human genome (GRCh38).
Reads were annotated using Ensembl (v87). Gene expression was then quantified using reads assigned to cells and confidently mapped to the genome.
Because each of the samples consisted of a pool of four individuals, natural genetic variation was used to identify which cells corresponded to which person. A list of common genetic variants was collected, defined as any SNP included in gnomAD 64 with a minor allele frequency higher than 1% in the Non-Finish European (NFE) population. Next, cellSNP Cardelino v0.99) 65 was used to generate pileups at these SNPs, resulting in one VCF file per sample. This information was then used by Cardelino 65 (v0.99) to infer which cells belong to the same individual. Any cells which remained unassigned (with less than 0.9 posterior probability of belonging to any individual) or were flagged as doublets were discarded. In general, over 85% of cells were unambiguously assigned to an individual (Supplementary Figure 3A) . This analysis was performed separately for each sample. To identify which individual from a given sample corresponded to an individual in a different sample, results from Cardelino were hierarchically clustered by genotypic distances between individuals.
Clustering separated genotypes into four distinct groups, each group corresponding to one of the profiled individuals.
Results from RNA quantification and genotype deconvolution were imported into R and analysed using Seurat (v2.3.4) 66 . Cells with less than 500 genes detected or with more than 7.5% mitochondrial genes were removed from the data set. Counts were normalized for library size and log-transformed using Seurat's default normalization parameters. Next, a publicly available list of cell cycle genes 67 was used to perform cell cycle scoring and assign cells to their respective stage of the cell cycle. Cell cycle, as well as any known sources of unwanted variation (mitochondrial content, cell size as reflected by UMI content, biological replicate and library preparation batch) were regressed using Seurat's built-in regression model. Highly variable genes were identified using Seurat and used to perform principal component analysis.
The first 30 principal components were used as an input for SNN clustering and for embedding using the uniform manifold approximation and projection (UMAP) 37 . Marker genes for each cluster were identified computationally using the Wilcoxon rank sum test implemented in Seurat. Multiple testing correction was performed using FDR. Cell cycle genes were excluded from this analysis. Moreover, marker genes were required to be expressed by at least 10% of the cells in the cluster at a minimum fold change of 0.25. A total of 5 clusters were identified in resting cells and 17 clusters were found in stimulated cells. Clusters were manually annotated according to their gene expression pattern, the cytokine which cells in the cluster were exposed to and the presence or absence of hallmark genes compiled from the literature.
UniFrac distance analysis 39 was used to test if cells exposed to two different cytokine conditions tended to form the same clusters. Pairwise UniFrac distances were computed for all combinations of cytokine conditions using all the cells captured for the respective conditions. The R package scUnifrac (v0.9.6) 40 was used as it was specifically adapted to deal with scRNA-seq data. All parameters were set to the default values (1,000 permutations, nDim = 4, ncluster = 10).
Pseudotime ordering and effectorness analysis
Cells were ordered into a branched pseudotime trajectory using Monocle (v2.12.0) and restricting the analysis to the highly variable genes identified by Seurat. This was done separately for each cytokine condition (resting, Th0, Th2, Th17 and iTreg), including both TN and TM cells. This resulted in five cytokine-specific pseudotime trajectories. Monocle was used to test for a significant correlation between gene expression and pseudotime in each trajectory.
A gene was defined as significantly associated with pseudotime if its estimated q value was lower than 0.01.
The four pseudotime trajectories derived from cytokine-stimulated T cells (Th0, Th2, Th17 and iTreg) were combined into a single numeric variable. To do this, he pseudotime values of cells within each condition were scaled to the range [0,1] and combined the cells into a single data set. Finally, the association between gene expression, effectorness and cytokine-stimulation was tested with the lm() function from base R. The expression of each gene was modelled as a linear function of T cell effectorness (a numeric variable in the [0,1] range) and cytokinestimulation (a categorical variable with levels Th0, Th2, Th17 and iTreg). An additional term was incorporated which accounted for potential interactions between these two variables, as specified in the following equation:
",$ = $ + $ + $ * $ + Where X is the expression of gene i in cell j (log2 of normalized UMIs), E the effectorness of cell j, C the cytokine cocktail cell j was exposed to and ε a random error term, which was assumed to follow a normal distribution with a mean of zero. The regression coefficients for effectorness, cytokine stimulation and the effectorness-cytokine interaction were represented, respectively, by α, β and γ. An estimate and a P value were derived for each of these coefficients in each tested gene. P values were corrected for the number of genes tested using the Benjamini-Hochberg procedure 57 . This analysis was restricted to the top variable genes identified by Seurat. All cells with zero-expression for a given gene were omitted. A coefficient was defined as significant if its corresponding FDR-adjusted P value was lower than 0.05.
Supplementary Figures
Supplementary Figure 1 
. PCA and correlation between RNA and protein expression. A)
Representative flow cytometry plots from three biologically independent samples. B) PCA plots from the full transcriptome and proteome of TN and TM cells following 16 hours of cytokine stimulations. Only stimulated cells were included in this analysis. C) Pearson correlations between RNA and protein logfold changes for all genes within each cytokine condition in TN and TM cells. D) Pearson correlations between RNA and protein log-fold changes for each gene across all cytokine conditions and cell types. Resting cells were excluded from this analysis. 
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